DocWire: African American men less likely to use targeted prostate cancer detection method

Study shows that African American men receive MRI-ultrasound biopsies less than white men

The findings of a new study published in the journal Prostate Cancer show that African American males are less likely to use a more targeted biopsy option for prostate cancer detection.

“Black men have a significantly higher incidence and are up to three times more likely to die of prostate cancer than white men,” says Dr. Abhinav Sidana, director of urologic oncology and assistant professor in the Division of Urology at the UC College of Medicine, a UC Health urologist and corresponding author on this study. “MRI-ultrasound biopsy has emerged as a promising option for the detection of prostate cancer. In this study, we wanted to identify differences in use of MRI-ultrasound biopsy between black and white men with possible prostate cancer.”

Read the full story.

Read the UC news release. 

Featured photo by Colleen Kelley/UC Creative Services

Related Stories

1

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.

3

Breakthrough skin science discovery

March 12, 2026

A research collaboration between the University of Cincinnati and global cosmetics company Kose led to the creation of a novel anti aging spot fading serum.